ODIN
ODIN identifies differential peaks between pairs of ChIP-seq datasets using a Hidden Markov Model to detect genomic regions with condition-specific differences in protein-DNA binding or chromatin modification.
Key Features:
- HMM-Based Framework: Employs Hidden Markov Models to model the sequential nature of genomic data and capture state patterns associated with peak presence and absence.
- Differential Peak Detection: Detects genomic regions with significant differences in peak intensity or presence between two ChIP-seq samples.
- Pairwise Comparison: Performs direct pairwise comparisons of two ChIP-seq datasets to identify condition-specific changes in binding or modifications.
- Statistical Analysis: Applies statistical methods to assess significance of differences in peak intensities or presence across paired datasets.
- Output Interpretation: Produces outputs that highlight differential peaks to support downstream biological interpretation.
Scientific Applications:
- Epigenetics: Investigating changes in histone modifications or DNA methylation patterns between different cell states or experimental conditions using ChIP-seq comparisons.
- Transcription Factor Binding Studies: Identifying differential transcription factor binding sites to infer regulatory mechanism changes between conditions.
- Gene Expression Regulation: Assessing how alterations in chromatin structure or factor binding correlate with changes in gene expression across conditions.
Methodology:
ODIN employs a Hidden Markov Model to process ChIP-seq data by representing genomic sequences as HMM states, applying statistical analysis to detect significant differences in peak intensity or presence, and producing outputs that highlight differential peaks.
Topics
Details
- Maturity:
- Mature
- Tool Type:
- workflow
- Programming Languages:
- Python
- Added:
- 1/13/2017
- Last Updated:
- 11/25/2024
Operations
Publications
Keravala A, Lee S, Thyagarajan B, Olivares EC, Gabrovsky VE, Woodard LE, Calos MP. Mutational Derivatives of PhiC31 Integrase With Increased Efficiency and Specificity. Molecular Therapy. 2009;17(1):112-120. doi:10.1038/mt.2008.241. PMID:19002165. PMCID:PMC2834998.